A Plea for Neutral Comparison Studies in Computational Sciences

由 Boulesteix, Anne-Laure, Lauer, Sabine, Eugster, Manuel J. A.
出版 2013

Proteomic Analysis of Detergent Resistant Membrane Domains during Early Interaction of Macrophages with Rough and Smooth Brucella melitensis

由 Lauer, Sabine A., Iyer, Srinivas, Sanchez, Timothy, Forst, Christian V., Bowden, Brent, Carlson, Kay, Sriranganathan, Nammalwar, Boyle, Stephen M.
出版 2014

Vacuolar uptake of host components, and a role for cholesterol and sphingomyelin in malarial infection

由 Lauer, Sabine, VanWye, Jeffrey, Harrison, Travis, McManus, Heather, Samuel, Benjamin U., Hiller, N.Luisa, Mohandas, Narla, Haldar, Kasturi
出版 2000

Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trial

由 Ferreira, João Pedro, Verma, Subodh, Fitchett, David, Ofstad, Anne Pernille, Lauer, Sabine, Zwiener, Isabella, George, Jyothis, Wanner, Christoph, Zinman, Bernard, Inzucchi, Silvio E.
發表在 Cardiovasc Diabetol (2020)

Adjuvant Subcutaneous Trastuzumab for HER2‐Positive Early Breast Cancer: Subgroup Analyses of Safety and Active Medical Conditions by Body Weight in the SafeHer Phase III Study

由 Jung, Kyung Hae, Ataseven, Beyhan, Verrill, Mark, Pivot, Xavier, De Laurentiis, Michelino, Al‐Sakaff, Nedal, Lauer, Sabine, Shing, Mona, Gligorov, Joseph, Azim, Hamdy A.
發表在 Oncologist (2018)

Empagliflozin for Patients With Presumed Resistant Hypertension: A Post Hoc Analysis of the EMPA-REG OUTCOME Trial

由 Ferreira, João Pedro, Fitchett, David, Ofstad, Anne Pernille, Kraus, Bettina Johanna, Wanner, Christoph, Zwiener, Isabella, Zinman, Bernard, Lauer, Sabine, George, Jyothis T, Rossignol, Patrick, Zannad, Faiez
發表在 Am J Hypertens (2020)

Cardio/Kidney Composite End Points: A Post Hoc Analysis of the EMPA‐REG OUTCOME Trial

由 Ferreira, João Pedro, Kraus, Bettina Johanna, Zwiener, Isabella, Lauer, Sabine, Zinman, Bernard, Fitchett, David H., Koitka‐Weber, Audrey, George, Jyothis T., Ofstad, Anne Pernille, Wanner, Christoph, Zannad, Faiez
發表在 J Am Heart Assoc (2021)

11 years’ follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial

由 Cameron, David, Piccart-Gebhart, Martine J, Gelber, Richard D, Procter, Marion, Goldhirsch, Aron, de Azambuja, Evandro, Castro, Gilberto, Untch, Michael, Smith, Ian, Gianni, Luca, Baselga, Jose, Al-Sakaff, Nedal, Lauer, Sabine, McFadden, Eleanor, Leyland-Jones, Brian, Bell, Richard, Dowsett, Mitch, Jackisch, Christian
發表在 Lancet (2017)